SATB1 and gastric cancer: In GC patients, although we have only 4 studies in this meta-analysis, SATB1 overexpression showed a significant correlation with mortality with a remarkably increased HR (combined HR: 1.88, 95% CI 1.44–2.46, p < 0.00001).